Call Today: 800-889-3898
Contact us for free information or to start a free case review.
Byetta®-related cases of hemorrhagic or necrotizing pancreatitis have been reported ever since this medical device was introduced in the United States in 2005 and in the UK in 2006. In 2007, the FDA issued an "Information for Healthcare Professionals" regarding the link between Byetta® (exenatide) and pancreatitis, and within another 12 months the FDA received reports of six more cases of Byetta®/pancreatitis cases.
In fact, nearly 400 Byetta®-user cases of pancreatitis were reported worldwide as of February 2009, according to a newsletter published by the MRHA (Medicines and Healthcare Regulatory Agency), the UK counterpart to the FDA. The number of Byetta® cases of pancreatitis continues to grow, and many lawsuits have been initiated regarding this deadly side effect of Byetta®.
Byetta® is prescribed by healthcare providers around the world to adult patients with type 2 diabetes. The injectable Byetta® pens are used twice a day to control a diabetic's glucose (blood sugar) level, before the morning and evening meals. The makers of Byetta® (San Diego-based Amylin Pharmaceuticals and Indianapolis-based Eli Lilly & Co.) explain that Byetta® works "at least four different ways" by:
Pancreatitis cases range from early-onset, relatively easily treated situations to severe, emergency cases that can be fatal. The inflammation of the pancreas can cause serious and uncontrollable bleeding resulting in death. The first U.S. Byetta® lawsuit filed by a Byetta® patient alleged that Byetta® maker Amylin failed to adequately warn prescribing physicians of:
Essentially all of the Byetta® cases and lawsuits since then have touched on these same points.
If you suspect that medical problems that you or your loved one experienced after starting Byetta® treatment may be actionable, talk to a Byetta® lawyer who represents victims of dangerous drugs and medical devices. He or she can discuss your circumstances with you in a no-cost, no-obligation consultation.
University of California, Los Angeles (UCLA) researchers have found that the use of the diabetes medications Byetta® and Januvia® may increase the risk of serious problems with the pancreas. Januvia® and Byetta® are both used to treat t...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.